|
Volumn 16, Issue 8, 2002, Pages 529-531
|
Haemorheological, platelet and endothelial factors in essential hypertension
|
Author keywords
Essential hypertension
|
Indexed keywords
ADRENERGIC RECEPTOR BLOCKING AGENT;
ANTIHYPERTENSIVE AGENT;
BETA THROMBOGLOBULIN;
CALCIUM CHANNEL BLOCKING AGENT;
CELL ADHESION MOLECULE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EFONIDIPINE;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
ENDOTHELIN 1;
FIBRINOGEN;
INTERCELLULAR ADHESION MOLECULE 1;
LIPID;
PADGEM PROTEIN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
QUINAPRIL;
RILMENIDINE;
THROMBOMODULIN;
TISSUE PLASMINOGEN ACTIVATOR;
VASCULAR CELL ADHESION MOLECULE 1;
VON WILLEBRAND FACTOR;
ARTERIAL PRESSURE;
BLOOD PRESSURE REGULATION;
BLOOD RHEOLOGY;
BLOOD VESSEL DIAMETER;
BLOOD VISCOSITY;
CAPILLARY DENSITY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFECT;
ENDOTHELIUM;
ENDOTHELIUM INJURY;
ERYTHROCYTE FILTERABILITY;
ESSENTIAL HYPERTENSION;
EVIDENCE BASED MEDICINE;
HEART INFARCTION;
HEART OUTPUT;
HEMATOLOGICAL PARAMETERS;
HEMODYNAMICS;
HUMAN;
NOTE;
PROGNOSIS;
PROTEIN ANALYSIS;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
RISK FACTOR;
SHORT COURSE THERAPY;
STATISTICAL ANALYSIS;
STROKE;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTE FUNCTION;
THROMBOSIS;
VASCULAR RESISTANCE;
BLOOD PLATELETS;
ENDOTHELIUM, VASCULAR;
HEMODYNAMIC PROCESSES;
HEMORHEOLOGY;
HUMANS;
HYPERTENSION;
|
EID: 0036670374
PISSN: 09509240
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jhh.1001456 Document Type: Note |
Times cited : (14)
|
References (6)
|